References
- Lindquist CH, Lindquist CA. Health behind bars: utilization and evaluation of medical care among jail inmates. J Community Health. 1999; 24: 285–303. [PUBMED], [INFOTRIEVE]
- Hammett TM, Gaiter JL, Crawford C. Reaching seriously at-risk populations: health interventions in criminal justice settings. Health Educ Behav. 1998; 25: 99–120. [PUBMED], [INFOTRIEVE]
- Abram KM, Teplin LA. Co-occurring disorders among mentally ill jail detainees. Implications for public policy. Am Psychol. 1991; 46: 1036–1045. [PUBMED], [INFOTRIEVE], [CROSSREF]
- National Institute of Justice. 1999. Annual Report on Drug Use among Adult and Juvenile Arrestees, Report No. 181426. Washington, DC, US Department of Justice, Office of Justice Programs, 2000.
- Wilson DJ. Drug Use, Testing, and Treatment in Jails, Report No. NCJ 179999. Washington, DC, US Department of Justice, Bureau of Justice Statistics. 2000
- Swartz JA, Lurigio AJ. Psychiatric illness and comorbidity among adult male jail detainees in drug treatment. Psychiatr Serv. 1999; 50: 1628–1630. [PUBMED], [INFOTRIEVE], [CSA]
- Bureau of Justice Statistics. Mental Health and Treatment of Inmates and Probationers, Report No. NCJ 174463. Washington, DC, US Department of Justice, Office of Justice Programs. 1999
- Lamb HR, Weinberger LE. Persons with severe mental illness in jails and prisons: a review. Psychiatr Serv. 1998; 49: 483–492. [PUBMED], [INFOTRIEVE], [CSA]
- Teplin LA. Psychiatric and substance abuse disorders among male urban jail detainees. Am J Public Health. 1994; 84: 290–293. [PUBMED], [INFOTRIEVE], [CSA]
- Teplin LA, Abram KM, McClelland GM. Prevalence of psychiatric disorders among incarcerated women. I. Pretrial jail detainees. Arch Gen Psychiatry. 1996; 53: 505–512. [PUBMED], [INFOTRIEVE], [CSA]
- Leukefeld CG, Tims FR. Drug abuse treatment in prisons and jails. J Subst Abuse Treat. 1993; 10: 77–84. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Baekeland F, Lundwall L. Dropping out of treatment: a critical review. Psychol Bull. 1975; 82: 738–783. [PUBMED], [INFOTRIEVE]
- Simpson DD, Joe GW, Rowan-Szal GA, Greener JM. Drug abuse treatment process components that improve retention. J Subst Abuse Treat. 1997; 14: 565–572. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend. 1997; 47: 227–235. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stark M. Dropping out of substance abuse treatment: a clinically orientated review. Clin Psychol Rev. 1992; 12: 93–116. [CROSSREF]
- Gottheil E, McLellan AT, Druley KA. Length of stay, patient severity and treatment outcome: sample data from the field of alcoholism. J Stud Alcohol. 1992; 53: 69–75. [PUBMED], [INFOTRIEVE]
- De Leon G. The therapeutic community: status and evolution. Int J Addict. 1985; 20: 823–844. [PUBMED], [INFOTRIEVE]
- Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug Abuse Treatment: A National Study of Effectiveness. Chapel Hill, NC, University of North Carolina Press. 1989; 165
- Simpson DD. The relation of time spent in drug abuse treatment to posttreatment outcome. Am J Psychiatry. 1979; 136: 1449–1453. [PUBMED], [INFOTRIEVE]
- Flynn PM, Craddock SG, Hubbard RL, Anderson J, Etheridge RM. Methodological overview and research design for DATOS. Psychol Addict Behav. 1997; 11: 230–243. [CROSSREF], [CSA]
- Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of one-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 1997; 11: 261–278. [CROSSREF], [CSA]
- Carroll KM, Power ME, Bryant K, Rounsville BJ. One-year follow-up status of treatment seeking cocaine abusers. Psychopathology and dependence severity as predictors of outcome. J Nerv Ment Dis. 1993; 181: 588–589. [CSA]
- Tidey JW, Mehl-Madrona L, Higgins ST, Badger GJ. Psychiatric symptom severity in cocaine-dependent outpatients: demographics, drug use characteristics, and treatment outcome. Drug Alcohol Depend. 1998; 50: 9–17. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Schubiner H, Tzelepis A, Isaacson JH, Warbasse LH, Zacharek M, Musial J. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. J Clin Psychiatry. 1995; 56: 146–150. [PUBMED], [INFOTRIEVE]
- Levy M, Saemann R, Oepen G. Neurological comorbidity in treatment-resistant dual-diagnosis patients. J Psychoactive Drugs. 1996; 28: 103–110. [PUBMED], [INFOTRIEVE], [CSA]
- Addington J, Addington D. Substance abuse and cognitive functioning in schizophrenia. J Psychiatry Neurosci. 1997; 22: 99–104. [PUBMED], [INFOTRIEVE], [CSA]
- McLellan AT, Luborsky L, O'Brien CP, Woody GE, Druley KA. Is treatment for substance abuse effective?. JAMA. 1982; 247: 1423–1428. [PUBMED], [INFOTRIEVE], [CROSSREF]
- McLellan AT, Luborsky L, Woody GE, O'Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch Gen Psychiatry. 1983; 40: 620–625. [PUBMED], [INFOTRIEVE]
- Woody GE, McLellan AT, Luborsky L, et al, Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the Veterans Administration-Penn study. Am J Psychiatry. 1984; 141: 1172–1177. [PUBMED], [INFOTRIEVE]
- Ross HE, Cutler M, Sklar SM. Retention in substance abuse treatment: role of psychiatric symptom severity. Am J Addict. 1997; 6: 293–303. [PUBMED], [INFOTRIEVE], [CSA]
- Broome KM, Flynn PM, Simpson DD. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Serv Res. 1999; 34: 791–806. [PUBMED], [INFOTRIEVE], [CSA]
- Charney DA, Paraherakis AM, Negrete JL, Gill KJ. The impact of depression on the outcome of addictions treatment. J Subst Abuse Treat. 1998; 15: 123–130. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pani PP, Trogu E, Contu P, Agus A, Gessa GL. Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug Alcohol Depend. 1997; 48: 119–126. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sterling RC, Gottheil E, Weinstein SP, Shannon DM. Psychiatric symptomatology in crack cocaine abusers. J Nerv Ment Dis. 1994; 182: 564–569. [PUBMED], [INFOTRIEVE], [CSA]
- Hiller M, Knight K, Simpson DD. Risk factors that predict dropout from corrections-based treatment for drug abuse. Prison Journal. 1999; 79: 411–430
- Lang MA, Belenko S. Predicting retention in a residential drug treatment alternative to prison program. J Subst Abuse Treat. 2000; 19: 145–160. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- National Institute of Justice. Evaluation of drug treatment in local corrections: NIJ research preview, Available at:. www. ncjrs.org/txtfiles/fs000173.txt, Accessed September 1. 2000
- Tunis S, Austin J, Morris M, Hardyman P, Bolyard M. Evaluation of Drug Treatment in Local Corrections, National Institute of Justice research report NCJ 159313. Washington, DC, US Department of Justice, National Institute of Justice;. 1996
- National Archive of Criminal Justice Data Web site. Available at:. www.icpsr.umich.edu/NACJD/index.html, Accessed September 1. 2000
- Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, John Wiley & Sons. 1989; 82–134
- Beck NC, Shekim W, Fraps C, Borgmeyer A, Witt A. Prediction of discharges against medical advice from an alcohol and drug misuse treatment program. J Stud Alcohol. 1983; 44: 171–180. [PUBMED], [INFOTRIEVE]
- Leigh G, Ogborne AC, Cleland P. Factors associated with patient dropout from an outpatient alcoholism treatment service. J Stud Alcohol. 1984; 45: 359–362. [PUBMED], [INFOTRIEVE]
- Saxon AJ, Wells EA, Fleming C, Jackson TR, Calsyn DA. Pre-treatment characteristics, program philosophy, and level of ancillary services as predictors of methadone maintenance treatment outcome. Addiction. 1996; 91: 1197–1209. [PUBMED], [INFOTRIEVE], [CROSSREF]
- Sorensen JL, Gibson D, Bernal G, Deitch D. Methadone applicant dropouts: impact of requiring involvement of friends or family in treatment. Int J Addict. 1985; 20: 1273–1280. [PUBMED], [INFOTRIEVE]
- Joe GW, Simpson DD. Retention in treatment of drug users: 1971–1972 DARP admissions. Am J Drug Alcohol Abuse. 1975; 2: 63–71. [PUBMED], [INFOTRIEVE]
- Wickizer T, Maynard C, Atherly A, et al, Completion rates of clients discharged from drug and alcohol treatment programs in Washington State. Am J Public Health. 1994; 84: 215–221. [PUBMED], [INFOTRIEVE], [CSA]
- De Leon G, Melnick G, Schoket D, Jainchill N. Is the therapeutic community culturally relevant? Findings on race/ethnic differences in retention in treatment. J Psychoactive Drugs. 1993; 25: 77–86. [PUBMED], [INFOTRIEVE]
- Fishbein DH. Female PCP-using jail detainees: proneness to violence and gender differences. Addict Behav. 1996; 21: 155–172. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Baldridge EB, Bessen HA. Phencyclidine. Emerg Med Clin North Am. 1990; 8: 541–550. [PUBMED], [INFOTRIEVE]
- Steinpresis RE. The behavioral and neurochemical effects of phencyclidine in humans and animals: some implications for modeling psychosis. Behav Brain Res. 1996; 74: 45–55. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Eklund C, Hiltunen AJ, Melin L, Borg S. Patient perceptions of psychological and physiological withdrawal symptoms and positive factors associated with gradual withdrawal from methadone maintenance treatment: a prospective study. Subst Use Misuse. 1997; 32: 1599–1618. [PUBMED], [INFOTRIEVE], [CSA]
- Levinson I, Galynker II, Rosenthal RN. Methadone withdrawal psychosis. J Clin Psychiatry. 1995; 56: 73–76. [PUBMED], [INFOTRIEVE]
- Gossop M, Strang J. A comparison of the withdrawal responses of heroin and methadone addicts during detoxification. Br J Psychiatry. 1991; 158: 697–699. [PUBMED], [INFOTRIEVE]
- Steadman HJ, Deane MW, Morrissey JP, Westcott ML, Salasin S, Shapiro S. A SAMHSA research initiative assessing the effectiveness of jail diversion programs for mentally ill persons. Psychiatr Serv. 1999; 50: 1620–1623. [PUBMED], [INFOTRIEVE], [CSA]
- RachBeisel J, Scott J, Dixon L. Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv. 1999; 50: 1427–1434. [PUBMED], [INFOTRIEVE], [CSA]
- Edens JF, Peters RH, Hills HA. Treating prison inmates with co-occurring disorders: an integrative review of existing programs. Behav Sci Law. 1997; 15: 439–457. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]